JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
Queen's Collaboration for Health Care Quality, Queen's University, Kingston, ON, Canada.
JBI Evid Synth. 2023 Mar 1;21(3):494-506. doi: 10.11124/JBIES-22-00430.
JBI recently began the process of updating and revising its suite of critical appraisal tools to ensure that these tools remain compatible with recent developments within risk of bias science. Following a rigorous development process led by the JBI Effectiveness Methodology Group, this paper presents the revised critical appraisal tool for the assessment of risk of bias for randomized controlled trials. This paper also presents practical guidance on how the questions of this tool are to be interpreted and applied by systematic reviewers, while providing topical examples. We also discuss the major changes made to this tool compared to the previous version and justification for why these changes facilitate best-practice methodologies in this field.
JBI 最近开始更新和修订其成套的批判性评价工具,以确保这些工具仍然与偏倚风险科学的最新发展保持兼容。在 JBI 有效性方法学小组的严格开发过程之后,本文提出了用于评估随机对照试验偏倚风险的修订版批判性评价工具。本文还就系统评价员如何解释和应用该工具的问题提供了实用指南,同时提供了相关主题示例。我们还讨论了与上一版本相比,该工具所做的主要更改,以及这些更改为何有助于该领域的最佳实践方法。